The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2020
DOI: 10.1016/j.nbd.2020.104869
|View full text |Cite
|
Sign up to set email alerts
|

The proportion of myeloid-derived suppressor cells in the spleen is related to the severity of the clinical course and tissue damage extent in a murine model of multiple sclerosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
51
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 36 publications
(64 citation statements)
references
References 90 publications
2
51
0
Order By: Relevance
“…In this study, we examined whether circulating PRR ligands produced constitutively by the gut microbiome regulate the splenic Ly6C high monocyte homeostasis and function during steady state. Our study focused on splenic Ly6C high monocytes as these immune cells play a regulatory role in the pathogenesis of many diseases such as EAE (Zhu et al, 2007;Melero-Jerez et al, 2020), ALS (Butovsky et al, 2012), stroke (Seifert and Offner, 2018;Pennypacker and Offner, 2015), atherosclerosis (Robbins et al, 2012;Swirski et al, 2016), ischemic myocardial injury (Leuschner et al, 2012;Swirski et al, 2009), lung ischemia-reperfusion injury (Hsiao et al, 2018), colitis (Griseri et al, 2012) and several tumor models (Cortez-Retamozo et al, 2012;Richards et al, 2013;Wu et al, 2018). We induced dysbiosis of the gut microbiome by administering a broad-spectrum antibiotic cocktail for a very short time period, compared with other studies (Kennedy et al, 2018), to identify the direct role of circulating PRR ligands on the maintenance of monocytes.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this study, we examined whether circulating PRR ligands produced constitutively by the gut microbiome regulate the splenic Ly6C high monocyte homeostasis and function during steady state. Our study focused on splenic Ly6C high monocytes as these immune cells play a regulatory role in the pathogenesis of many diseases such as EAE (Zhu et al, 2007;Melero-Jerez et al, 2020), ALS (Butovsky et al, 2012), stroke (Seifert and Offner, 2018;Pennypacker and Offner, 2015), atherosclerosis (Robbins et al, 2012;Swirski et al, 2016), ischemic myocardial injury (Leuschner et al, 2012;Swirski et al, 2009), lung ischemia-reperfusion injury (Hsiao et al, 2018), colitis (Griseri et al, 2012) and several tumor models (Cortez-Retamozo et al, 2012;Richards et al, 2013;Wu et al, 2018). We induced dysbiosis of the gut microbiome by administering a broad-spectrum antibiotic cocktail for a very short time period, compared with other studies (Kennedy et al, 2018), to identify the direct role of circulating PRR ligands on the maintenance of monocytes.…”
Section: Discussionmentioning
confidence: 99%
“…During the onset of EAE, splenic Ly6C high monocytes acquire an immunosuppressive function (Zhu et al, 2007), which they maintain within the central nervous system (CNS) as they express Nos2 and Arg1, hallmark genes of myeloid-derived suppressor cells (Zhu et al, 2007;Giladi et al, 2020). Their abundance has recently been related to a milder EAE course (Melero-Jerez et al, 2020). Splenic Ly6C high monocytes are also involved in the regulation of amyotrophic lateral sclerosis (ALS) because they acquire an M1 signature before disease onset and treatment with an anti-Ly6C monoclonal antibody leads to reduced monocyte recruitment to the spinal cord, diminished neuronal loss, and extended survival in mice (Butovsky et al, 2012).…”
Section: Introductionmentioning
confidence: 99%
“…Although the adoptive transfer was conducted with MOG-Th1 cells and the active immunization model is highly skewed toward a Th1 cell repertoire, we can’t ignore that many other immune cells contribute to EAE neuroinflammation. Peripheral myeloid cells, including macrophages, dendritic cells, and neutrophils, exhibit a prominent role during EAE, and are a major component of MS lesions ( Levesque et al, 2016 ; Giles et al, 2018 ; Tsai et al, 2019 ; Ifergan and Miller, 2020 ; Lu et al, 2020 ; Melero-Jerez et al, 2020 ; Owens et al, 2020 ; Tanwar et al, 2020 ; Wasser et al, 2020 ). Likewise, myeloid cells are both primary sources and targets of IL-20 subfamily cytokines ( Hsu et al, 2006 , 2011 ; Kragstrup et al, 2008 ; Wolk et al, 2008 , 2009a ; Wang et al, 2012 ; Rutz et al, 2014 ; Mayer et al, 2015 ; Bech et al, 2016 ; Kako et al, 2016 ; Gough et al, 2017 ; Senolt et al, 2017 ; Zhang et al, 2017 ; Dabitao et al, 2018 ; Niess et al, 2018 ; Weng et al, 2019 ).…”
Section: Discussionmentioning
confidence: 99%
“…A1 positive myeloid cells have been found to be upregulated during the progression of EAE [59][60][61] and their presence was shown to be inversely correlated with the severity of disease with greater expression at the earlier stage [61,80]. These A1 expressing cells, especially the myeloid-derived suppressor cells are hypothesized to inhibit T-cell activation and therefore, may dampen the autoimmune-mediated demyelination in EAE [81,82]. A report by Xu et al provided data showing a less severe EAE phenotype in mice treated with the arginase inhibitor, amino-6-boronohexanoic acid (ABH) [57].…”
Section: Plos Onementioning
confidence: 99%